Buprenorphine
Product Images NDC 58118-3156

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 58118-3156). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Chemical Structure For Buprenorphine HCl, Usp Has The Molecular Formula C29 H41 No4 • HCl And The Molecular Weight Is 504.10. It Is A White Or Off-white Crystalline Powder, Sparingly S (Image 1)

Chemical structure of Buprenorphine hydrochloride showing the detailed molecular arrangement with hydroxyl, methoxy, and cyclopropyl groups.*

FDA Label Image

Tablets Debossed (Image 2)

The image shows the front and back of a medication box for Buprenorphine by Clinical Solutions Wholesale, LLC. The packaging includes the proprietary name, labeler name, and a barcode on the back. The box is primarily white with orange design elements. No specific strength or dosage form is legible from the image.*

FDA Label Image

Tablets Debossed (Image 3)

Buprenorphine sublingual tablets packaging label from Clinical Solutions Wholesale, LLC. The label shows the product name 'Buprenorphine' and indicates presence of 6 sublingual tablets in the package. The label includes the NDC number 58118-3156. The packaging uses a mainly white and yellow color scheme with black text.*

FDA Label Image

Small Image (Image 4)

An illustration showing a hand placing a tablet into an open mouth, positioned on the tongue. The image depicts the act of administering an oral tablet, relevant for demonstrating how to take the medication Buprenorphine.*

FDA Label Image

Buprenorphine Sl 2mg Tablets 30 Count Blister Card (Image 5)

Label for Buprenorphine SL 2 mg tablets showing product name, strength, dosage form, and quantity of 30 tablets. Manufactured by Actavis Pharma, Inc. in Parsippany, NJ, and labeled by Clinical Solutions Wholesale, LLC. Includes NDC 58118-3156-8, lot number SAMPLE123, and expiration date June 2020. Label features a QR code and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.